Cargando…

Supplementation with Bifidobacterium longum subspecies infantis EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol

INTRODUCTION: The Global Platform for the Prevention of Autoimmune Diabetes-SINT1A Study is designed as a randomised, placebo-controlled, double-blind, multicentre, multinational, primary prevention study aiming to assess whether daily administration of Bifidobacterium infantis from age 7 days to 6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziegler, Anette-Gabriele, Arnolds, Stefanie, Kölln, Annika, Achenbach, Peter, Berner, Reinhard, Bonifacio, Ezio, Casteels, Kristina, Elding Larsson, Helena, Gündert, Melanie, Hasford, Joerg, Kordonouri, Olga, Lundgren, Markus, Oltarzewski, Mariusz, Pekalski, Marcin L, Pfirrmann, Markus, Snape, Matthew D, Szypowska, Agnieszka, Todd, John A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Diabetes and Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578987/ https://www.ncbi.nlm.nih.gov/pubmed/34753762 http://dx.doi.org/10.1136/bmjopen-2021-052449

Ejemplares similares

Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
por: Ziegler, Anette-Gabriele, et al.
Publicado: (2019)

Persistence of Supplemented Bifidobacterium longum subsp. infantis EVC001 in Breastfed Infants
por: Frese, Steven A., et al.
Publicado: (2017)

Bifidobacterium longum Subspecies infantis Strain EVC001 Decreases Neonatal Murine Necrotizing Enterocolitis
por: Lueschow, Shiloh R., et al.
Publicado: (2022)

Reduced colonic mucin degradation in breastfed infants colonized by Bifidobacterium longum subsp. infantis EVC001
por: Karav, Sercan, et al.
Publicado: (2018)

Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD‐02 study design and first results
por: Winkler, Christiane, et al.
Publicado: (2019)

Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial
por: Smilowitz, Jennifer T., et al.
Publicado: (2017)

Erratum to: Safety and tolerability of Bifidobacterium longum subspecies infantis EVC001 supplementation in healthy term breastfed infants: a phase I clinical trial
por: Smilowitz, Jennifer T., et al.
Publicado: (2017)

Bifidobacterium longum subsp. infantis EVC001 Administration Is Associated with a Significant Reduction in the Incidence of Necrotizing Enterocolitis in Very Low Birth Weight Infants
por: Tobias, Joseph, et al.
Publicado: (2022)

Colonization by B. infantis EVC001 modulates enteric inflammation in exclusively breastfed infants
por: Henrick, Bethany M., et al.
Publicado: (2019)

Bifidobacterium longum Subspecies infantis (B. infantis) in Pediatric Nutrition: Current State of Knowledge
por: Chichlowski, Maciej, et al.
Publicado: (2020)

Elevations in blood glucose before and after the appearance of islet autoantibodies in children
por: Warncke, Katharina, et al.
Publicado: (2022)

Phylogenomic disentangling of the Bifidobacterium longum subsp. infantis taxon
por: Tarracchini, Chiara, et al.
Publicado: (2021)

Differentiation of Bifidobacterium longum subspecies longum and infantis by quantitative PCR using functional gene targets
por: Lawley, Blair, et al.
Publicado: (2017)

Revisiting the Metabolic Capabilities of Bifidobacterium longum susbp. longum and Bifidobacterium longum subsp. infantis from a Glycoside Hydrolase Perspective
por: Blanco, Guillermo, et al.
Publicado: (2020)

970 Safety of Bifidobacterium longum infantis and Lactobacillus reuteri in Bangladeshi Infants
por: Hoy-Schulz, Yana Emmy, et al.
Publicado: (2014)

Geertgen Tot Sint Jans
por: Boon, Karel G.
Publicado: (1967)

Dengue Serosurvey in Sint Eustatius
por: Leslie, Teresa, et al.
Publicado: (2014)

Dietary supplementation with Bifidobacterium longum subsp. infantis (B. infantis) in healthy breastfed infants: study protocol for a randomised controlled trial
por: Awasthi, Smita, et al.
Publicado: (2016)

Impact of Probiotic B. infantis EVC001 Feeding in Premature Infants on the Gut Microbiome, Nosocomially Acquired Antibiotic Resistance, and Enteric Inflammation
por: Nguyen, Marielle, et al.
Publicado: (2021)

B. infantis EVC001 Is Well-Tolerated and Improves Human Milk Oligosaccharide Utilization in Preterm Infants in the Neonatal Intensive Care Unit
por: Bajorek, Sarah, et al.
Publicado: (2022)

Comparative Genomics Analyses Reveal the Differences between B. longum subsp. infantis and B. longum subsp. longum in Carbohydrate Utilisation, CRISPR-Cas Systems and Bacteriocin Operons
por: Li, Mingjie, et al.
Publicado: (2021)

Bifidobacterium longum Subspecies infantis Bacteremia in 3 Extremely Preterm Infants Receiving Probiotics
por: Esaiassen, Eirin, et al.
Publicado: (2016)

Primary prevention of beta-cell autoimmunity and type 1 diabetes – The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives
por: Ziegler, A.G., et al.
Publicado: (2016)

Novel large deletion involving EVC and EVC2 in Ellis–van Creveld syndrome
por: Sato, Hiroki, et al.
Publicado: (2022)

EVC-EVC2 complex stability and ciliary targeting are regulated by modification with ubiquitin and SUMO
por: Barbeito, Pablo, et al.
Publicado: (2023)

Mining Milk for Factors which Increase the Adherence of Bifidobacterium longum subsp. infantis to Intestinal Cells
por: Quinn, Erinn M., et al.
Publicado: (2018)

Bifidobacterium longum spp. infantis 35624® en el síndrome de intestino irritable : la ciencia y la evidencia /
por: Valdovinos Díaz, Miguel Angel
Publicado: (2018)

Oligosaccharide Binding Proteins from Bifidobacterium longum subsp. infantis Reveal a Preference for Host Glycans
por: Garrido, Daniel, et al.
Publicado: (2011)

Proteomic Analysis of Bifidobacterium longum subsp. infantis Reveals the Metabolic Insight on Consumption of Prebiotics and Host Glycans
por: Kim, Jae-Han, et al.
Publicado: (2013)

Bifidobacterium longum subsp. infantis in experimental necrotizing enterocolitis: alterations in inflammation, innate immune response, and the microbiota
por: Underwood, Mark A., et al.
Publicado: (2014)

Draft Genome Sequence of Bifidobacterium longum subsp. infantis BI-G201, a Commercialization Strain
por: Song, Jinan, et al.
Publicado: (2020)

Evaluation of 2’-Fucosyllactose and Bifidobacterium longum Subspecies infantis on Growth, Organ Weights, and Intestinal Development of Piglets
por: Daniels, Victoria C., et al.
Publicado: (2021)

Milk phospholipids protect Bifidobacterium longum subsp. infantis during in vitro digestion and enhance polysaccharide production
por: Kosmerl, Erica, et al.
Publicado: (2023)

Chikungunya virus outbreak in Sint Maarten, 2013–2014
por: Henry, Maria, et al.
Publicado: (2017)

SDR, EVC, and SDREVC: Limitations and Extensions
por: Hunter, E.D., et al.
Publicado: (2023)

Evc2 is a positive modulator of Hedgehog signalling that interacts with Evc at the cilia membrane and is also found in the nucleus
por: Blair, Helen J, et al.
Publicado: (2011)

Riboflavin Biosynthesis and Overproduction by a Derivative of the Human Gut Commensal Bifidobacterium longum subsp. infantis ATCC 15697
por: Solopova, Ana, et al.
Publicado: (2020)

Influence of 2′-Fucosyllactose and Bifidobacterium longum Subspecies infantis Supplementation on Cognitive and Structural Brain Development in Young Pigs
por: Sutkus, Loretta T., et al.
Publicado: (2022)

Bifidobacterium longum subsp. infantis utilizes human milk urea to recycle nitrogen within the infant gut microbiome
por: You, Xiaomeng, et al.
Publicado: (2023)

Factors associated with inadequate diagnosis of COPD: On-Sint cohort analysis
por: Fernández-Villar, Alberto, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ueq0v347rutssa6f9bu6adrgok